Study

EORTC-2148-MRD-HNCG-MG

Minimal Residual Disease Assessment

Trial Status

Recruiting

Dates

Date of activation: 23-May-2025

Data management at EORTC

Yes

Design

Cohort
Not randomized / N.A.

Targeted Sample size

EORTC Groups: 250 - All Groups: 250

Study Staff

  • Benjamin Besse (Study Coordinator), Gustave Roussy, VILLEJUIF CEDEX
  • Rebecca Lee (Study Co-Coordinator), The Christie NHS Foundation Trust, Manchester
  • Paul Lorigan (Study Co-Coordinator), The Christie NHS Foundation Trust, Manchester
  • Jean-Pascal Machiels (Study Co-Coordinator), Cliniques Universitaires Saint-Luc, Brussels
  • Marc Oliva Bernal (Y-ECI Coordinator), ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia), L' Hospitalet De Llobregat
  • Alexandra Jouret (Project Manager), EORTC Headquarters, Brussels
  • Bert Dhondt (Clinical Research Physician), EORTC Headquarters, Brussels
  • Anne-Sophie Govaerts (Clinical Scientist), EORTC Headquarters, Brussels
  • Jedelyn Cabrieto (Statistician), EORTC Headquarters, Brussels
  • Michal Kicinski (Statistician), EORTC Headquarters, Brussels
  • Fanny Grillet (TR Scientist), EORTC Headquarters, Brussels
  • Cedric Mallien (TR Scientist), EORTC Headquarters, Brussels
  • Benedicte Demeulder (Junior Clinical Operations Manager), EORTC Headquarters, Brussels
  • Shani De Coster (Data Manager), EORTC Headquarters, Brussels
  • Arnaud Poncin (Data Manager), EORTC Headquarters, Brussels
  • Jelle Stans (Regulatory Affairs Manager), EORTC Headquarters, Brussels
  • Anja Mestnik (Junior RAM), EORTC Headquarters, Brussels
  • Lucy Sepulveda (Junior RAM), EORTC Headquarters, Brussels
  • Dagmar Moravcova (Clinical Operations Assistant), EORTC Headquarters, Brussels

Type of cancer

  • Melanoma
  • Head and Neck

Participating groups

  • EORTC Head and Neck Cancer Group
  • EORTC Melanoma Group

Recruiting centers

  • AZORG (previous Onze Lieve Vrouw ZK) (Aalst, Belgium)
  • Athens University - Attikon University General Hospital (Athens, Greece)
  • CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
  • CHU Mont Godinne - UCL Namur (Yvoir, Belgium)
  • CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
  • Centre Eugene Marquis (RENNES CEDEX, France)
  • Centre Hospitalier D'Annecy Genevois (Pringy, France)
  • Centre Hospitalier Departemental Vendee (LA ROCHE SUR YON CEDEX 9, France)
  • Centre Leon Berard (Lyon, France)
  • Centre de Radiotherapie Pierre Curie (Beuvry, France)
  • Clatterbridge Cancer Center - Liverpool (Liverpool, United Kingdom)
  • Cliniques Universitaires Saint-Luc (Brussels, Belgium)
  • Gustave Roussy (VILLEJUIF CEDEX, France)
  • Hospital Clinic de Barcelona (Barcelona, Spain)
  • ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
  • IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy)
  • Institut Bergonie (Bordeaux, France)
  • Istituto Clinico Humanitas (Rozzano, Milano, Italy)
  • NHS Lothian - Western General Hospital (Edinburgh, United Kingdom)
  • Unidade Local de Saúde Gaia e Espinho (previously Cen.Hospitalar Vila Nova Gaia / Espinho) (Vila Nova De Gaia, Portugal)
  • UniversitaetsSpital Zurich (Zurich, Switzerland)
  • Universitaetsklinikum Greifswald der Ernst Morizt Arndt Univ. Greifswald AoR (Greifswald, Germany)
  • Universitair Ziekenhuis Gent (Gent, Belgium)
  • University Hospital Motol (Prague, Czech Republic)

Centers to be activated

  • CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
  • CHU de Lille (LILLE CEDEX, France)
  • CHU de Nice - Hopital De L'Archet (NICE, France)
  • Centre Hospitalier D'Annecy Genevois (Pringy, France)
  • Centro Hospitalar Universitario Lisboa Norte - Hospital Sta. Maria (Lisboa, Portugal)
  • Centro Hospitalar de Lisboa Ocidental- Sao Francisco Xavier Hospital (Lisboa, Portugal)
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (Berlin, Germany)
  • East and North Hertfordshire NHS Trust – Mount Vernon Hospital (Northwood, United Kingdom)
  • Greater Poland Cancer Centre (Poznan, Poland)
  • Guy's and St Thomas' NHS - St Thomas Hospital (London, United Kingdom)
  • Hospital Clinic de Barcelona (Barcelona, Spain)
  • Hospital Universitario 12 De Octubre (Madrid, Spain)
  • Hospital Universitario QuironSalud (Madrid, Spain)
  • Hospital Universitario Virgen De La Victoria (Malaga, Spain)
  • IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy)
  • IRCCS Ospedale San Martino (Genova, Italy)
  • IRCCS-Regina Elena National Cancer Center (Roma, Italy)
  • Institut Bergonie (Bordeaux, France)
  • Instituto Portugues de Oncologia do Porto Francisco Gentil (Porto, Portugal)
  • Klinikum Nuernberg- Standort Nord (Nuernberg, Germany)
  • Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
  • Medical University Of Gdansk (Gdansk, Poland)
  • National Cancer Institute (Vilnius, Lithuania)
  • North Estonia Medical Centre - Mustamae unit (Tallinn, Estonia)
  • Santa Maria della Misericordia Hospital (Perugia, Italy)
  • St George's University Hospital NHS Trust Foundation (London, United Kingdom)
  • St. James'S Hospital (Dublin, Ireland)
  • The Christie NHS Foundation Trust (Manchester, United Kingdom)
  • Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center (Hamburg, Germany)
  • Universitair Ziekenhuis Brussel (Brussels, Belgium)
  • University Clinical Center of Serbia - Clinic for ENT and MFH (Belgrade, Serbia)
  • Vilnius University Hospital Santaras Clinics Branch-National Cancer Center (Vilnius, Lithuania)
  • Warmia-Mazury Oncology center Olsztynie (Olsztyn, Poland)

Study

EORTC-2148-MRD-HNCG-MG

Minimal Residual Disease Assessment

Linked Studies

EORTC-1553-SPECTA

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access